United States - English - NLM (National Library of Medicine)

a-s medication solutions - dicloxacillin sodium (unii: 4hzt2v9kx0) (dicloxacillin - unii:cof19h7wbk) - dicloxacillin 250 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of dicloxacillin sodium capsules usp and other antibacterial drugs, dicloxacillin sodium capsules usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. dicloxacillin is indicated in the treatment of infections caused by penicillinase-producing staphylococci which have demonstrated susceptibility to the drug. cultures and susceptibility tests should be performed initially to determine the causative organisms and their sensitivity to the drug (see clinical pharmacology – susceptibility plate testing ). dicloxacillin may be used to initiate therapy in suspected cases of resistant staphylococcal in

Ireland - English - HPRA (Health Products Regulatory Authority)

athlone laboratories ltd - flucloxacillin sodium - powder for oral solution - 125 mg/5ml - beta-lactamase resistant penicillins; flucloxacillin

Ireland - English - HPRA (Health Products Regulatory Authority)

athlone laboratories ltd - flucloxacillin sodium - powder for oral solution - 125 mg/5ml - beta-lactamase resistant penicillins; flucloxacillin

Ireland - English - HPRA (Health Products Regulatory Authority)

brillpharma (ireland) limited - flucloxacillin sodium ph. eur. - powder for oral solution - 125 mg/5ml - beta-lactamase resistant penicillins; flucloxacillin

Ireland - English - HPRA (Health Products Regulatory Authority)

brillpharma (ireland) limited - flucloxacillin sodium ph. eur. - powder for oral solution - 250 mg/5ml - beta-lactamase resistant penicillins; flucloxacillin

Ireland - English - HPRA (Health Products Regulatory Authority)

athlone pharmaceuticals limited - flucloxacillin sodium - powder for oral solution - beta-lactamase resistant penicillins; flucloxacillin

Ireland - English - HPRA (Health Products Regulatory Authority)

athlone pharmaceuticals limited - flucloxacillin sodium - powder for oral solution - beta-lactamase resistant penicillins; flucloxacillin

Ireland - English - HPRA (Health Products Regulatory Authority)

wockhardt uk limited - flucloxacillin sodium monohydrate - powder for solution for injection/infusion - 250 milligram(s) - beta-lactamase resistant penicillins; flucloxacillin

Ireland - English - HPRA (Health Products Regulatory Authority)

wockhardt uk limited - flucloxacillin sodium monohydrate - powder for solution for injection/infusion - 500 milligram(s) - beta-lactamase resistant penicillins; flucloxacillin

Ireland - English - HPRA (Health Products Regulatory Authority)

wockhardt uk limited - flucloxacillin sodium monohydrate - powder for solution for injection/infusion - 1 gram(s) - beta-lactamase resistant penicillins; flucloxacillin